Key statistics
As of last trade OrthoPediatrics Corp (2X7:FRA) traded at 13.80, 2.99% above its 52-week low of 13.40, set on Oct 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.80 |
|---|---|
| High | 13.80 |
| Low | 13.80 |
| Bid | 14.60 |
| Offer | 14.90 |
| Previous close | 13.90 |
| Average volume | 3.78 |
|---|---|
| Shares outstanding | 25.08m |
| Free float | 16.87m |
| P/E (TTM) | -- |
| Market cap | 419.04m USD |
| EPS (TTM) | -1.96 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 07:00 GMT.
More ▼
Announcements
- OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity
- OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
- OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches
- OrthoPediatrics to Participate in Upcoming Conferences
- OrthoPediatrics Corp. Reports Third Quarter 2025 Financial Results
- OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family
- OrthoPediatrics Corp. to Report Third Quarter Financial Results on October 28, 2025
- OrthoPediatrics Corp. Announces Preliminary Third Quarter 2025 Revenue and Revised 2025 Guidance
- OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
- OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.
More ▼
